Dabur India reported double-digit consolidated sales growth for the June quarter, its first in nearly three years. This performance was supported by a strong international business and a return to volume growth in the domestic market. Investors are now tracking whether this momentum can be sustained to improve overall profitability.
Dabur India reported double-digit consolidated revenue growth for the quarter ending June 2026, marking a significant improvement in its operational performance. This recovery, the first of its kind in 11 quarters, comes as the company benefits from a notable uptick in consumer spending, particularly within rural India where demand has begun to outpace urban centers. The company estimates a 7% year-on-year rise in domestic volumes, a sharp contrast to the sluggish performance seen in previous periods.
Segment Growth and International Strength
The Home and Personal Care segment emerged as a primary growth engine, with hair oils and shampoos expected to deliver high teens growth. In the oral care category, established brands like Red Toothpaste and Meswak continue to maintain steady demand. While the healthcare segment faces minor hurdles in specific sub-categories like glucose, products such as Hajmola and Pudin Hara are providing stability. Simultaneously, the food business, supported by the integration of the Badshah portfolio, is contributing to the company's double-digit revenue expansion.
Dabur’s international operations remain a strong pillar, with growth projected at 17% in rupee terms. Despite geopolitical complexities affecting markets in West Asia, operations in Turkey, Egypt, and Bangladesh have shown resilience. This global diversification helps mitigate the impact of localized demand fluctuations in the Indian market.
Margins and Financial Outlook
Despite ongoing pressure from input costs, the company appears to have managed its profitability through strategic pricing actions. Gross margins are estimated to reach 48.5%, representing a 147 basis point expansion compared to the previous year. Operating profit margins are expected to hold steady at 19.5%, leading to an anticipated 12% year-on-year increase in net profit.
While these figures indicate a turnaround, the company faces the challenge of maintaining this pace against larger peers in the fast-moving consumer goods sector. Analysts have noted that while recent performance is positive, consistent growth in the healthcare and beverage segments remains a key area for further improvement. With the stock trading at 39 times its estimated FY27 earnings, the market is evaluating whether the company can sustain this revenue momentum in the coming quarters. Investors should monitor future updates on rural consumption trends and the company’s ability to defend its margins if commodity costs remain elevated.